Dexcom | DXCM - 股票



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 35.59B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


股票 更改 日
Abbott USD 6.99B 501M 2026-03
Align Technology USD 212.24M 2.7M 2026-06
AtriCure USD 83.92M 2.78M 2026-06
Baxter International USD 2.26B 57M 2026-06
Becton, Dickinson and Co. USD 3.32B 41M 2026-06
Boston Scientific USD 3.24B 118M 2026-06
Cooper Companies USD 876.4M 30.4M 2025-12
Dexcom USD 726.4M 32.8M 2026-06
Edwards Lifesciences USD 1.13B 12.2M 2026-06
Globus Medical USD 810.9M 38.3M 2026-06
Inogen USD 25.08M 762K 2025-09
Insulet USD 484.8M 22.3M 2026-06
Integra LifeSciences USD 492M 3.03M 2026-06
J&J USD 15.14B 561M 2026-06
Medtronic USD 6.31B 153M 2025-12
Merit Medical Systems USD 374.11M 21.73M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Solventum Corp USD 1.04B 49M 2026-06
Stryker USD 5.52B 102M 2026-06
Tandem Diabetes Care USD 135.11M 8.71M 2026-06
Teleflex USD 351.91M 28.95M 2026-06
West Pharmaceutical Services USD 447.4M 5.2M 2026-06
Zimmer Biomet Holdings USD 2.27B 23.5M 2026-06